Back
BlueLinx Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
44
BXC
BlueLinx Holdings
Last Price:
104.16
Seasonality Move:
-5.95%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
44
BlueLinx Holdings (BXC)
is a Sell
Is BlueLinx Holdings a Buy, Sell or Hold?
- The current BlueLinx Holdings [BXC] share price is $104.56. The Score for BXC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BXC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BXC Stock Price Chart
What is BlueLinx Holdings's stock price today?
-
The BlueLinx Holdings share price today is $104.56
The current trend is moderately bullish and BXC is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.43
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
BXC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.71 | Buy |
Relative Strength Index (14 RSI): | 53.81 | Buy |
Chaikin Money Flow: | -97889 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (95.81 - 106.29) | Buy |
Bollinger Bands (100): | (93.29 - 108.97) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 43.18 | Sell |
Chaikin Money Flow: | -435004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.76 - 58.26) | Sell |
Bollinger Bands (100): | (40.14 - 54.08) | Buy |
BXC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 106.37 | Sell |
20-day SMA: | 100.93 | Buy |
50-day SMA: | 103.26 | Buy |
200-day SMA: | 108.58 | Sell |
8-day EMA: | 104.88 | Sell |
20-day EMA: | 102.86 | Buy |
50-day EMA: | 101.97 | Buy |
200-day EMA: | 102.22 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.08 | Sell |
20-day SMA: | 56.96 | Sell |
50-day SMA: | 52.99 | Buy |
200-day SMA: | 46.88 | Buy |
8-day EMA: | 56.5 | Sell |
20-day EMA: | 56.46 | Sell |
50-day EMA: | 53.4 | Buy |
200-day EMA: | 47.32 | Buy |
BlueLinx Holdings Earnings Growth & BXC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.66 per share, an increase next quarter of $1.17 per share, a decrease this year of $4.61 per share, and an increase next year of $1.43 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
BlueLinx Holdings Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |